19 March 2013 in Annals of Internal Medicine
FNfor the GeoSentinel Surveillance Network
for the GeoSentinel Surveillance Network
+12
International travel is rapidly increasing, as are travelers presenting with illness after they return home. Researchers used a large surveillance database to examine the frequency and patterns of ... Chinese translation Background: International travel continues to increase, particularly to Asia and Africa. Clinicians are increasingly likely to be consulted for advice before travel or by ill re...
1 November 2008 in Vaccine
Yellow fever (YF) vaccine has been used for prevention of YF since 1937 with over 500 million doses administered. However, rare reports of severe adverse events following vaccination have raised concerns about the vaccine's safety. We reviewed reports of adverse events following YF vaccination reported to the U.S. Vaccine Adverse Event Reporting System (VAERS) from 2000 to 2006. We used estimates of age and sex distribution of administered doses obtained from a 2006 survey of authorized vaccine providers to calculate age- and sex-specific reporting rates of all serious adverse events (SAE), anaphylaxis, YF vaccine-associated neurotropic disease, and YF vaccine-associated viscerotropic disease. Reporting rates of SAEs were substantially higher in males and in persons aged > or =60 years. These findings reinforce the generally acceptable safety profile of YF vaccine, but highlight the importance of physician and traveler education regarding the risks and benefits of YF vaccination, particularly for travelers > or =60 years of age. Vaccination should be limited to persons traveling to areas where the risk of YF is expected to exceed the risk of serious adverse events after vaccination, or if not medically contraindicated, where national regulations require proof of vaccination to prevent introduction of YF.
15 March 2007 in Clinical Infectious Diseases
Yellow fever continues to occur in regions of Africa and South America, despite the availability of effective vaccines. Recently, some cases of sever
1 October 2020 in Placenta
1 October 2010 in Vaccine